Dr. Matthias Weiss
Claim this profileThedaCare Regional Cancer Center
Area of expertise
Cancer
Matthias Weiss has run 11 trials for Cancer. Some of their research focus areas include:
Lung Cancer
Matthias Weiss has run 11 trials for Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
ThedaCare Regional Cancer Center
ThedaCare Regional Medical Center - Neenah
Clinical Trials Matthias Weiss is currently running
Pembrolizumab + Radiation vs Chemotherapy + Radiation
for Head and Neck Cancer
This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Radiation therapy uses high energy radiation or protons to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Carboplatin is also in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. Giving pembrolizumab alone after surgery may work better than the usual approach in shrinking recurrent or primary head and neck squamous cell carcinoma.
Recruiting
1 award
Phase 2
31 criteria
Olaparib
for Pancreatic Cancer
This phase II trial investigates how well the addition of olaparib following completion of surgery and chemotherapy works in treating patients with pancreatic cancer that has been surgically removed (resected) and has a pathogenic mutation in BRCA1, BRCA2, or PALB2. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy.
Recruiting
0 awards
Phase 2
32 criteria
More about Matthias Weiss
Clinical Trial Related
7 years of experience running clinical trials · Led 41 trials as a Principal Investigator · 13 Active Clinical Trials
Treatments Matthias Weiss has experience with
- Carboplatin
- Paclitaxel
- Nivolumab
- Biospecimen Collection
- Pembrolizumab
- Atezolizumab
Breakdown of trials Matthias Weiss has run
Cancer
Lung Cancer
Pancreatic Cancer
Colon Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthias Weiss specialize in?
Matthias Weiss focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Matthias Weiss currently recruiting for clinical trials?
Yes, Matthias Weiss is currently recruiting for 13 clinical trials in Appleton Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Matthias Weiss has studied deeply?
Yes, Matthias Weiss has studied treatments such as Carboplatin, Paclitaxel, Nivolumab.
What is the best way to schedule an appointment with Matthias Weiss?
Apply for one of the trials that Matthias Weiss is conducting.
What is the office address of Matthias Weiss?
The office of Matthias Weiss is located at: ThedaCare Regional Cancer Center, Appleton, Wisconsin 54911 United States. This is the address for their practice at the ThedaCare Regional Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.